Phase I Clinical Facilities
View images from our facilities in the US, London and Sweden.
View now
Article
Early Phase Optimization Strategies
As payers balk at rising drug prices and patent expirations threaten the industry’s revenue
streams, pharmaceutical companies worldwide are looking for ways to cut costs associated with
drug development and, simultaneously, speed the process up.
Read more
Phase I Systems
Find out how our Phase I system enables you to make critical decisions earlier.
View now
News
QUINTILES ANNOUNCES CLINICAL PHARMACOLOGY ALLIANCE WITH ASTRAZENECA
November 2, 2009 - Quintiles has entered into in an industry-leading clinical pharmacology alliance with AstraZeneca to deliver AstraZeneca’s clinical pharmacology studies across multiple therapy areas and around the globe.
Read more
QUINTILES TO OPEN PHASE I UNIT IN INDIA
January 27, 2009 – Quintiles Transnational Corp. announced a partnership with Apollo Hospitals Group to open a Phase I clinical trial unit in Hyderabad, India.
Read more
The results are in.
Quintiles has been named the top CRO by two independent surveys. Learn why at the June 2009 DIA Annual Meeting.
More information
Learn more about Phase I/IIa
Phase I/IIa
Promote Safe, Clinically Advanced Phase I/IIa Studies
You need to safely advance your drug candidate through phase I/IIa. The key to achieving this objective – on time – is to focus on maximizing critical data through strategic study design.
With four clinical phase I and phase IIa units in England, Sweden (2) and the United States, we offer:
- Study units across the globe – operating as one when sharing data and expertise
- Leading-edge, scientifically stringent analytical and technology solutions
- Proven study capabilities
- Complex
- Regulatory
- Vaccine
Detail-driven Phase I / Phase IIa Services, Processes and Staff
Together, we determine innovative and adaptive clinical study designs and Phase I/Phase IIA services required to reach your objectives. The result? Accurate, quality data to help you make faster, better informed decisions.
And throughout the study, our experts – leading authorities in early clinical trials phases research – consult and advise you. The impact? You receive the best actionable insight.
